Import exemption for drugs under advance licensing allows bulk drug imports without manufacturing site registration or import licence. Imports of approved and unapproved drugs under the Advance Licensing Scheme are exempt from the Drugs and Cosmetics registration procedure. The circular clarifies that bulk drugs imported under Para 4.2.7 of the EXIM Policy, 2002-07 may be imported without manufacturing site registration and without the import licence required by the cited Ministry of Health notification.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Import exemption for drugs under advance licensing allows bulk drug imports without manufacturing site registration or import licence.
Imports of approved and unapproved drugs under the Advance Licensing Scheme are exempt from the Drugs and Cosmetics registration procedure. The circular clarifies that bulk drugs imported under Para 4.2.7 of the EXIM Policy, 2002-07 may be imported without manufacturing site registration and without the import licence required by the cited Ministry of Health notification.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.